Company Profile
Exelixis Stock Price, News & Analysis
- Ticker:
- EXEL
- Exchange:
- NASDAQ
- Sector:
- 小分子
- Location:
- Headquartered in Alameda, California and listed on NASDAQ, Exelixis is followed within the oncology universe for its mix of commercial scale and pipeline optionality.
Stock performance
51.34 USD (-0.02%)
Close
Last updated: June 23, 2026 at 00:00
12.9B USD
Market cap
Why the stock is moving
EXEL is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Exelixis is an oncology-focused biopharmaceutical company best known for its established commercial base and continued pipeline work in cancer. Investors follow the stock for launch durability and the next wave of oncology catalysts.
Geographic Base and Sector Classification
Headquartered in Alameda, California and listed on NASDAQ, Exelixis is followed within the oncology universe for its mix of commercial scale and pipeline optionality.
Business Model Characteristics
Exelixis combines product cash flow with ongoing oncology development, so the market watches earnings, label progress, and pipeline expansion together.
Position Within the Biotechnology Landscape
Compared with early-stage oncology peers, Exelixis sits on the more mature side of the landscape, where commercial durability and next-line programs both matter.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Exelixis (EXEL)?
Exelixis (EXEL) most recently closed at 51.34 USD, a -0.02% move versus the previous session.
What is the market cap of Exelixis (EXEL)?
Exelixis currently has a market capitalization of 12.9B USD on BioPharmSignal.
What does Exelixis do?
Exelixis is an oncology-focused biopharmaceutical company best known for its established commercial base and continued pipeline work in cancer. Investors follow the stock for launch durability and the next wave of oncology catalysts.
On which exchange is EXEL stock listed?
Exelixis (EXEL) is associated with NASDAQ, Headquartered in Alameda, California and listed on NASDAQ, Exelixis is followed within the oncology universe for its mix of commercial scale and pipeline optionality., 小分子.
What is Exelixis?
Exelixis is an oncology-focused biopharmaceutical company best known for its established commercial base and continued pipeline work in cancer.
Which conditions is Exelixis targeting with Exelixis?
Exelixis is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
What is Investors?
Investors follow the stock for launch durability and the next wave of oncology catalysts.